Abstract
Background Retrospective self-reports of childhood maltreatment are widely used in research and clinical practice. However, their validity has been questioned due to potential depressive bias. Yet, systematic investigations of this matter are sparse. Thus, we investigate if and to what extent retrospective maltreatment reports vary in relation to longitudinal changes in depressive symptomatology.
Methods Two-year temporal stability of maltreatment reports was assessed via the Childhood Trauma Questionnaire (CTQ). Diagnosis and depressive symptoms were assessed using clinical interview and the Beck Depression Inventory. From two independent cohorts (MACS and MNC) we included a total of n=347 major depressive disorder (MDD) patients, n=419 healthy controls (HC), and a subsample with a lifetime first depressive episode between both assessments (n=27). Analysis plan and hypotheses were preregistered prior to data sighting.
Results Maltreatment reports were highly stable in HC and MDD patients across both cohorts (ICC=.956; 95%-CI[.949, .963] and ICC=.950; 95%-CI[.933, .963]) and temporal stability did not differ between groups. Stability was lower for cutoff-based maltreatment categorization (K=.551; 95%-CI[.479, .622] and K=.507; 95%-CI[.371, .640]). Baseline maltreatment reports were associated with concurrent and future depression severity. However, longitudinal changes in depression severity predicted variability in CTQ scores only to a small extent across cohorts (b=0.101, p=.009, R2=.021 and b=0.292, p=.320), with the effect being driven by emotional maltreatment subscales.
Conclusions Findings suggest that the CTQ provides temporally stable self-reports of childhood maltreatment in healthy and depressed populations, and are only marginally biased by depressive symptomatology. Gradual rather than categorical conceptualization of maltreatment is advised for improving psychometric quality.
Competing Interest Statement
Tilo Kircher received unrestricted educational grants from Servier, Janssen, Recordati, Aristo, Otsuka, neuraxpharm. This funding is not associated with the current work. On behalf of all authors, the corresponding author states that there is no conflict of interest and nothing to disclose.
Clinical Protocols
Funding Statement
This work is part of the German multicenter consortium 'Neurobiology of Affective Disorders. A translational perspective on brain structure and function', funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; Forschungsgruppe/Research Unit FOR2107). DFG funding in the context of the FOR2107 was received by: TK (speaker FOR2107; DFG grant numbers KI 588/14-1, KI 588/14-2, KI 588/15-1, KI 588/17-1), UD (co-speaker FOR2107; DA 1151/5-1, DA 1151/5-2, DA 1151/6-1), AK (KR 3822/5-1, KR 3822/7-2), IN (NE 2254/1-2), TH (HA 7070/2-2, HA7070/3, HA7070/4). This work was further supported by the Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Munster (Grant Dan3/012/17 to UD and SEED 11/19 to NO). EL was additionally supported by the Christiane Nuesslein-Vollhard Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The MNC was approved by the ethics committee of the Medical Faculty of University of Munster (2007-307-f-S). The MACS was approved by the Ethics Committees of the Medical Faculties, University of Marburg (AZ: 07/14) and University of Munster (AZ: 2014-422-b-S). The study was performed in accordance with the ethical guidelines and regulations. All participants gave written informed consent prior to examination and received financial compensation.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest: Tilo Kircher received unrestricted educational grants from Servier, Janssen, Recordati, Aristo, Otsuka, neuraxpharm. This funding is not associated with the current work. On behalf of all authors, the corresponding author states that there is no conflict of interest and nothing to disclose.
Data Availability
The data that support the findings of this study are openly available in the Open Science Framework at https://osf.io/9754h/, DOI: 10.17605/OSF.IO/9754H.
Abbreviations
- CTQ
- Childhood Trauma Questionnaire
- HC
- healthy controls
- MACS
- Marburg-Münster Affective Disorders Cohort Study
- MDD
- major depressive disorder
- MNC
- Münster Neuroimaging Cohort
